statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.028
SG - Singapore	222
IT - Italia	161
CN - Cina	142
HK - Hong Kong	109
DE - Germania	90
BR - Brasile	80
VN - Vietnam	75
RU - Federazione Russa	74
SE - Svezia	49
IE - Irlanda	45
CA - Canada	39
GB - Regno Unito	38
AT - Austria	29
FR - Francia	20
BD - Bangladesh	19
IN - India	19
FI - Finlandia	18
KR - Corea	17
UA - Ucraina	16
AR - Argentina	14
TR - Turchia	13
DK - Danimarca	12
PL - Polonia	12
BE - Belgio	11
ID - Indonesia	10
JP - Giappone	10
ZA - Sudafrica	10
ES - Italia	8
SA - Arabia Saudita	7
VE - Venezuela	7
CO - Colombia	5
EC - Ecuador	5
MX - Messico	5
CL - Cile	4
IQ - Iraq	4
PK - Pakistan	4
MY - Malesia	3
NL - Olanda	3
TN - Tunisia	3
AE - Emirati Arabi Uniti	2
CH - Svizzera	2
DO - Repubblica Dominicana	2
EG - Egitto	2
KW - Kuwait	2
LT - Lituania	2
LY - Libia	2
MA - Marocco	2
NP - Nepal	2
UZ - Uzbekistan	2
AM - Armenia	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
HN - Honduras	1
IL - Israele	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LK - Sri Lanka	1
LV - Lettonia	1
ME - Montenegro	1
MM - Myanmar	1
MT - Malta	1
MU - Mauritius	1
MZ - Mozambico	1
NI - Nicaragua	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
TH - Thailandia	1
ZW - Zimbabwe	1
Totale	2.489

Nome	#
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients	456
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates	451
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease	407
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy	249
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706)	244
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience	225
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study	188
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes	183
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes	171
Totale	2.574

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	18	0	0	0	0	0	0	0	0	0	0	0	18
2021/2022	94	16	17	25	9	0	1	5	1	2	7	4	7
2022/2023	171	13	22	19	20	16	21	10	7	15	8	14	6
2023/2024	169	10	7	16	18	23	48	23	2	12	3	0	7
2024/2025	388	14	27	30	21	39	18	23	4	26	61	51	74
2025/2026	1.202	160	65	88	174	129	52	198	42	84	87	50	73
Totale													2.574

Bicocca Open Archive